Sino Biopharm Sets HKD0.05 Final Dividend for FY2025

Bulletin Express03-26

Sino Biopharmaceutical Limited (“Sino Biopharm”) has announced a final ordinary dividend of HKD0.05 per share for the financial year ended 31 December 2025, according to a filing released on 26 March 2026.

Shareholders will vote on the distribution at the annual general meeting scheduled for 17 June 2026. If approved, the stock will trade ex-dividend on 24 June 2026. The share register will be closed from 26 June to 02 July 2026, with the record date fixed for 02 July 2026. Dividend cheques are slated for dispatch on 20 July 2026.

The payment will be made entirely in Hong Kong dollars at HKD1:HKD1, and the filing specifies that no withholding tax will be applied. Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, is the appointed share registrar.

The board comprises six executive directors—Ms. Tse Theresa Y Y, Mr. Tse Ping, Ms. Cheng Cheung Ling, Mr. Tse Eric S Y, Mr. Tse Hsin, and Mr. Tian Zhoushan—alongside five independent non-executive directors: Mr. Lu Zhengfei, Mr. Li Dakui, Ms. Lu Hong, Mr. Zhang Lu Fu, and Dr. Li Kwok Tung Donald.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment